The head of California’s Obamacare exchange reflects on a decade of running one of the most successful parts of the ACA.
Podcast
The FDA Super Bowl
We break down the controversial FDA user fee process and the legislative bonanza it kicks off every five years.
Answering the Call, Part 1: America’s New Mental Health Crisis Line
A new nationwide crisis line launches in July 2022. Will it be ready to meet America’s mental health needs?
Harm Reduction’s Road From Fringe to Federal Drug Policy
How a once taboo strategy to keep drug users safe has become more mainstream and what that could mean for our overdose crisis.
Medicare’s Unprecedented Alzheimer’s Drug Decision
A doctor, a patient and a former federal official weigh in on Medicare’s recent move to restrict access to a new Alzheimer’s treatment.
Winter Hiatus Episodes
Explore the guest and rerun episodes we featured in the Tradeoffs podcast feed during our winter 2021-2022 hiatus.
Rethinking Telehealth’s Role in Treating Addiction
COVID opened the door to treating addiction remotely. Now policymakers have to decide whether to keep telehealth around.
Let’s Make a Deal…on Drug Prices
Democrats are on the brink of passing a historic set of drug price reforms. How will they impact patients, insurers and the drug industry?
Has Medicaid Managed Care Delivered On Its Promise?
Letting private insurers offer Medicaid coverage was supposed to lower costs and improve care. Did it work?
The Costly, Confusing Medicare Choices Facing 62 Million Americans
It’s Medicare open enrollment time, but shopping for a new plan is much harder and riskier than it seems.
